My Portfolio

Teva Pharmaceutical Industries Limited.. TEVA-IL:Tel Aviv Stock Exchange

*Data is delayed | Exchange | ILS

Last | 06/03/26 EEST

9,338.00UNCH (UNCH)

52 week range

5,305.00 - 11,350.00

Open0.00
Day High0.00
Day Low0.00
Prev Close9,338.00
52 Week High11,350.00
52 Week High Date02/03/26
52 Week Low5,305.00
52 Week Low Date08/04/25

Latest On Teva Pharmaceutical Industries Limited..

Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolioApril 29, 2026CNBC.com
FDA approves leucovorin as first drug for rare genetic disorderMarch 10, 2026CNBC.com
Trade Tracker: Joe Terranova buys the EIS and trims the OIHMarch 2, 2026CNBC.com
Inside Einhorn's eclectic stock portfolio: The famed value investor shuns AIFebruary 18, 2026CNBC.com
FDA chief Marty Makary says more drugs should be available over the counterFebruary 18, 2026CNBC.com
Goldman says these five stocks, including Nvidia, are too attractive to ignoreFebruary 14, 2026CNBC.com
Teva CEO Richard Francis sits down with Jim CramerJanuary 28, 2026CNBC.com
Jim Cramer's top 10 things to watch in the stock market MondayJanuary 12, 2026CNBC.com
This year's biotech laggards primed for 2026 recovery: Goldman Sachs' RichterDecember 19, 2025CNBC.com
Stocks making the biggest moves premarket: Ferrari, PepsiCo, Delta and moreOctober 9, 2025CNBC.com

Key Stats

Market Cap10.875T
Shares Out1.16B
10 Day Average Volume1.08M
Dividend-
Dividend Yield-
Beta0.83

Latest On Teva Pharmaceutical Industries Limited..

Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolioApril 29, 2026CNBC.com
FDA approves leucovorin as first drug for rare genetic disorderMarch 10, 2026CNBC.com
Trade Tracker: Joe Terranova buys the EIS and trims the OIHMarch 2, 2026CNBC.com
Inside Einhorn's eclectic stock portfolio: The famed value investor shuns AIFebruary 18, 2026CNBC.com
FDA chief Marty Makary says more drugs should be available over the counterFebruary 18, 2026CNBC.com
Goldman says these five stocks, including Nvidia, are too attractive to ignoreFebruary 14, 2026CNBC.com
Teva CEO Richard Francis sits down with Jim CramerJanuary 28, 2026CNBC.com
Jim Cramer's top 10 things to watch in the stock market MondayJanuary 12, 2026CNBC.com
This year's biotech laggards primed for 2026 recovery: Goldman Sachs' RichterDecember 19, 2025CNBC.com
Stocks making the biggest moves premarket: Ferrari, PepsiCo, Delta and moreOctober 9, 2025CNBC.com

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close9,338.00
52 Week High11,350.00
52 Week High Date02/03/26
52 Week Low5,305.00
52 Week Low Date08/04/25
Market Cap10.875T
Shares Out1.16B
10 Day Average Volume1.08M
Dividend-
Dividend Yield-
Beta0.83

RATIOS/PROFITABILITY

EPS (TTM)-
P/E (TTM)-
Fwd P/E (NTM)-
EBITDA (TTM)14.512B
ROE (TTM)21.59%
Revenue (TTM)48.848B
Gross Margin (TTM)52.77%
Net Margin (TTM)8.95%
Debt To Equity (MRQ)202.08%

EVENTS

Earnings Date-
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Content From Our Affiliates

Piper Sandler Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)June 1, 2026TipRanks
Teva Shareholders Back Board, Executive Pay and AuditorMay 28, 2026TipRanks
Teva commits to Veeva Vault CRMMay 27, 2026TipRanks
Teva announces EMA acceptance of MAA for olanzapine long-acting injectableMay 21, 2026TipRanks
Einhorn’s DME takes stakes in StubHub, Paramount, buys more PelotonMay 17, 2026TipRanks

Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract...

Sol Barer Ph.D.

Independent Chairman of the Board

Richard Francis

President, Chief Executive Officer, Director

Eliyahu Kalif

Chief Financial Officer, Executive Vice President

Christine Fox

Executive Vice President - U.S. Commercial

Eric Hughes

Executive Vice President - Global R&D, Chief Medical Officer

Address

124 Dvora Hanevi'a St.

Tel Aviv-yafo

6944020

Israel

https://www.tevapharm.com/